Abstract

BackgroundApplication of the 2010 ACR/EULAR Criteria for RA to early inflammatory arthritis cohorts permits an enhanced sensitivity for diagnosis compared to the historic 1987 ACR criteria but risks loss of...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
Peter C Taylor ... Jason A Hackney
Annals of the Rheumatic Diseases | VOL. 62
Peter C Taylor, et. al.Peter C Taylor ... Jason A Hackney
02 Oct 2019
FRI0151 The Association between Age and Inflammatory Findings on Hand and Foot MRI in Early Arthritis, Rheumatoid Arthritis and Symptom-Free Controls
L Mangnus ... W.P Nieuwenhuis
Annals of the Rheumatic Diseases | VOL. 75
L Mangnus, et. al.L Mangnus ... W.P Nieuwenhuis
01 Jun 2016
THU0100 In early inflammatory arthritis a lymphoid pathotype signficantly associates with requirement for biologic therapy at 12 months follow up: results from the pathobiology of early arthritis cohort (PEAC)
M Lewis ... I Mcinnes
Annals of the Rheumatic Diseases | VOL. 76
M Lewis, et. al.M Lewis ... I Mcinnes
01 Jun 2017
Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis
Sally Youssef ... Yasser El Miedany
Joint Bone Spine | VOL. 75
Sally Youssef, et. al.Sally Youssef ... Yasser El Miedany
20 Sep 2007
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers